Optogenetic drug discovery platform
Drug discovery platform
An integrated discovery engine that pairs a first-of-its-kind optogenetic screening platform with novel chemistry tools and machine learning. Light-controlled activation of cellular stress and aging pathways generates high-throughput, high-fidelity datasets; AI models trained on those datasets propose molecules, which are then validated experimentally and fed back into the platform.
- Optogenetic control of biological pathways with millisecond and micron resolution
- Proprietary aging datasets across cellular and whole-organism models
- Machine learning models that propose and rank drug hypotheses
- Novel chemistry tooling for small-molecule optimization
- Closed loop between AI prediction and high-throughput experimental validation
Built for
Pharmaceutical partners and, ultimately, patients with age-related and cardiometabolic diseases such as neurodegeneration, cancer, diabetes and osteoarthritis